Clinical Trials · NCT01976728
LutrePulse Hypogonadotropic Hypogonadism
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 39
- Start date
- Apr 2014
- Locations
- 35 sites, United States, Canada
- Primary endpoint
- Ovulation Rate